Brain Cancer clinical trials in New Hampshire

2 actively recruiting brain cancer trials at 1 site across New Hampshire.

Data from ClinicalTrials.gov · last refreshed 2026-09-07

Phase 2 Recruiting Network

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to …

Sponsor: Children's Oncology Group

NCT ID: NCT04684368

Sites in New Hampshire:

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Phase 1/1b Study of IAM1363 in HER2 Cancers

This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.

Sponsor: Iambic Therapeutics, Inc

NCT ID: NCT06253871

Sites in New Hampshire:

Dartmouth Hitchcock Medical — Lebanon, New Hampshire

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-09-07